BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23020581)

  • 21. Defects in methylthioadenosine phosphorylase are associated with but not responsible for methionine-dependent tumor cell growth.
    Tang B; Li YN; Kruger WD
    Cancer Res; 2000 Oct; 60(19):5543-7. PubMed ID: 11034100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
    Chen ZH; Olopade OI; Savarese TM
    Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.
    Bataille F; Rogler G; Modes K; Poser I; Schuierer M; Dietmaier W; Ruemmele P; Mühlbauer M; Wallner S; Hellerbrand C; Bosserhoff AK
    Lab Invest; 2005 Jan; 85(1):124-36. PubMed ID: 15492751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
    Yang B; Chen J; Zhang X; Cao J
    Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma.
    Berasain C; Hevia H; Fernández-Irigoyen J; Larrea E; Caballería J; Mato JM; Prieto J; Corrales FJ; García-Trevijano ER; Avila MA
    Biochim Biophys Acta; 2004 Nov; 1690(3):276-84. PubMed ID: 15511635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTAP gene deletion in endometrial cancer.
    Wong YF; Chung TK; Cheung TH; Nobori T; Chang AM
    Gynecol Obstet Invest; 1998; 45(4):272-6. PubMed ID: 9623796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
    Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
    Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
    Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
    Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
    Zhang S; Kong WJ
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas.
    Chow WA; Bedell V; Gaytan P; Borden E; Goldblum J; Hicks D; Slovak ML
    Cancer Genet Cytogenet; 2006 Apr; 166(2):95-100. PubMed ID: 16631464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
    Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma].
    Bai W; Li W; Chen X; Wang T
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):254-6. PubMed ID: 16739377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
    Christopher SA; Diegelman P; Porter CW; Kruger WD
    Cancer Res; 2002 Nov; 62(22):6639-44. PubMed ID: 12438261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy.
    Batova A; Diccianni MB; Nobori T; Vu T; Yu J; Bridgeman L; Yu AL
    Blood; 1996 Oct; 88(8):3083-90. PubMed ID: 8874207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
    Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
    Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
    Meyer S; Wild PJ; Vogt T; Bataille F; Ehret C; Gantner S; Landthaler M; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
    Exp Dermatol; 2010 Aug; 19(8):e251-7. PubMed ID: 20500769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors.
    Huang HY; Li SH; Yu SC; Chou FF; Tzeng CC; Hu TH; Uen YH; Tian YF; Wang YH; Fang FM; Huang WW; Wei YC; Wu JM; Li CF
    Clin Cancer Res; 2009 Nov; 15(22):6963-72. PubMed ID: 19887491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
    Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.